Page last updated: 2024-10-31

methylphenidate and Behavior Disorders

methylphenidate has been researched along with Behavior Disorders in 133 studies

Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.

Research Excerpts

ExcerptRelevanceReference
"The aims of this study were to evaluate the neuropsychological characteristics of the restrictive (R) subtype according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition and the attention-deficit/hyperactivity disorder (ADHD) combined (CB) type and predominantly inattentive (PI) type subtypes and to evaluate whether methylphenidate (MPH) affects neurocognitive test battery scores according to these subtypes."7.80Effect of methylphenidate on neurocognitive test battery: an evaluation according to the diagnostic and statistical manual of mental disorders, fourth edition, subtypes. ( Ardic, UA; Durak, S; Ercan, E; Ercan, ES; Ipci, M; Yuce, D, 2014)
"We describe an open trial of psychostimulants (primarily methylphenidate sustained release [SR]) added to selective serotonin reuptake inhibitors (SSRIs; primarily fluoxetine) during the course of pharmacologic treatment of men with paraphilias and paraphilia-related disorders (PRDs)."5.09Psychostimulant augmentation during treatment with selective serotonin reuptake inhibitors in men with paraphilias and paraphilia-related disorders: a case series. ( Hennen, J; Kafka, MP, 2000)
"Methylphenidate or dextroamphetamine was used to treat 17 of 32 patients with AIDS-related complex who were referred for neuropsychiatric evaluation of symptoms representative of cognitive and/or affective dysfunction."5.06Psychostimulant response in AIDS-related complex patients. ( Fernandez, F; Holmes, VF; Levy, JK, 1989)
"Antipsychotics, particularly risperidone, appear to be effective in reducing problem behaviors in children with intellectual disability."4.93Pharmacotherapy for mental health problems in people with intellectual disability. ( Findling, RL; Ji, NY, 2016)
"The aims of this study were to evaluate the neuropsychological characteristics of the restrictive (R) subtype according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition and the attention-deficit/hyperactivity disorder (ADHD) combined (CB) type and predominantly inattentive (PI) type subtypes and to evaluate whether methylphenidate (MPH) affects neurocognitive test battery scores according to these subtypes."3.80Effect of methylphenidate on neurocognitive test battery: an evaluation according to the diagnostic and statistical manual of mental disorders, fourth edition, subtypes. ( Ardic, UA; Durak, S; Ercan, E; Ercan, ES; Ipci, M; Yuce, D, 2014)
"Methylphenidate was associated with trends towards increased blood pressure and reported anxiety."2.84The efficacy and safety of extended-release methylphenidate following traumatic brain injury: a randomised controlled pilot study. ( Dymowski, AR; Olver, JH; Owens, JA; Ponsford, JL; Ponsford, M; Willmott, C, 2017)
"This study does not support the expectation that optimally dosed stimulant treated children with ADHD should routinely receive psychosocial treatment to further reduce ADHD- and related symptoms."2.73Does brief, clinically based, intensive multimodal behavior therapy enhance the effects of methylphenidate in children with ADHD? ( Emmelkamp, PM; Oosterlaan, J; Prins, PJ; van der Oord, S, 2007)
"Thirty patients with primary brain tumors underwent neuropsychologic assessment before and during treatment with methylphenidate."2.69Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. ( Levin, VA; Meyers, CA; Valentine, AD; Weitzner, MA, 1998)
"Parents of children with mental retardation or borderline IQ who took part in two drug studies were surveyed by mail 4 weeks after their involvement."2.68Consumer satisfaction with involvement in drug research: a social validity study. ( Aman, MG; Wolford, PL, 1995)
"Seven patients with AIDS-related cognitive and emotional deficits had neuropsychologic testing and then were treated with methylphenidate or dextroamphetamine in individualized doses."2.67Central nervous system stimulants as symptomatic treatments for AIDS-related neuropsychiatric impairment. ( Angrist, B; d'Hollosy, M; Diamond, G; Sanfilipo, M; Satriano, J; Simberkoff, M; Weinreb, H, 1992)
" Any long-term psychotropic treatment in childhood raises concerns about possible adverse neurological and psychiatric outcomes."2.61Neurological and psychiatric adverse effects of long-term methylphenidate treatment in ADHD: A map of the current evidence. ( Ansari, MT; Banaschewski, T; Buitelaar, JK; Carucci, S; Coghill, D; Danckaerts, M; Dittmann, RW; Falissard, B; Garas, P; Groom, MJ; Hall, CL; Hollis, C; Inglis, SK; Kochhar, P; Konrad, K; Kovshoff, H; Krinzinger, H; Liddle, EB; McCarthy, S; Nagy, P; Neubert, A; Roberts, S; Sayal, K; Sonuga-Barke, E; Wong, ICK; Xia, J; Zuddas, A, 2019)
"Comorbid psychiatric disorders should be addressed with disorder-specific therapies while associated symptoms also often improve with treatment of the ADHD core symptoms."2.49[Adult attention deficit/hyperactivity disorder, associated symptoms and comorbid psychiatric disorders: diagnosis and pharmacological treatment]. ( Alm, B; Paslakis, G; Schredl, M; Sobanski, E, 2013)
"Those disorders discussed are attention deficit disorder, conduct disorders, anxiety disorders, sleep disorders, schizophrenia, autism, Tourette's syndrome, mental retardation, depressive illness, manic depressive illness, eating disorders, and enuresis."2.37Pharmacologic treatment of psychiatric and neurodevelopmental disorders in children and adolescents (Part 1). ( McDaniel, KD, 1986)
"The most common comorbidities were substance use disorders (39."1.43Psychiatric Comorbidity at the Time of Diagnosis in Adults With ADHD: The CAT Study. ( Balanzá-Martínez, V; García-García, P; Piñeiro-Dieguez, B; Soler-López, B, 2016)
"The association of substance use disorders (SUD) with attention-deficit disorder (ADHD), co-morbid mental disorders, and medication has only been studied in isolation and in rather small samples."1.40Substance use disorders in association with attention-deficit/hyperactivity disorder, co-morbid mental disorders, and medication in a nationwide sample. ( Bisgaard, C; Steinhausen, HC, 2014)
"OROS-methylphenidate was reported as the most helpful methylphenidate class formulation, with 74% reporting it at least somewhat helpful."1.39Caregiver survey of pharmacotherapy to treat attention deficit/hyperactivity disorder in individuals with Williams syndrome. ( Andridge, RR; Coury, DL; Foster, JE; Martens, MA; McClure, KE; Seyfer, DL, 2013)
" Dosage was inversely associated with risk."1.38Methylphenidate and risk of serious cardiovascular events in adults. ( Bilker, WB; Cziraky, MJ; Daniel, GW; Guevara, JP; Hennessy, S; Kimmel, SE; Newcomb, C; Schelleman, H; Strom, BL, 2012)
"Methylphenidate (MPH) was given to mice while they were also kept under an enrichment condition."1.38Methylphenidate improves the behavioral and cognitive deficits of neurogranin knockout mice. ( Huang, FL; Huang, KP, 2012)
"Treatment with methylphenidate was more effective and better tolerated than treatment with clonidine."1.31[Functioning, comorbidity and treatment of 141 adults with attention deficit hyperactivity disorder (ADHD) at a psychiatric outpatient department]. ( Aeckerlin, LP; Buitelaar, JK; Kooij, JJ, 2001)
" Often, these agents are used in combination with other medications."1.30Drug interactions with psychostimulants. ( DeVane, CL; Markowitz, JS; Morrison, SD, 1999)
" Higher dosage was associated with fewer diagnoses of alcoholism or suicide attempts."1.30Childhood inattention-overactivity, aggression, and stimulant medication history as predictors of young adult outcomes. ( Loney, J; Paternite, CE; Salisbury, H; Whaley, MA, 1999)
"Bereavement after diagnosing AIDS or other HIV disease, psychological symptoms secondary to brain disease and the social consequences of having AIDS all interact to produce a devastating illness where the patient may be intensely grieving, demented and totally rejected by all of society."1.27Psychosocial aspects of AIDS. ( Goldmeier, D, 1987)
"A possibly different mechanism in hypersomnia and hypersexuality is speculated."1.26The Kleine-Levine syndrome--a variant? ( Nair, NP; Yassa, R, 1978)

Research

Studies (133)

TimeframeStudies, this research(%)All Research%
pre-199061 (45.86)18.7374
1990's21 (15.79)18.2507
2000's29 (21.80)29.6817
2010's22 (16.54)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Krinzinger, H1
Hall, CL1
Groom, MJ1
Ansari, MT1
Banaschewski, T2
Buitelaar, JK3
Carucci, S1
Coghill, D1
Danckaerts, M1
Dittmann, RW1
Falissard, B1
Garas, P1
Inglis, SK1
Kovshoff, H1
Kochhar, P1
McCarthy, S1
Nagy, P1
Neubert, A1
Roberts, S1
Sayal, K1
Sonuga-Barke, E1
Wong, ICK1
Xia, J1
Zuddas, A1
Hollis, C1
Konrad, K1
Liddle, EB1
Faraone, SV5
Espadas, M1
Insa, I1
Chamorro, M1
Alda-Diez, JA1
Martens, MA1
Seyfer, DL1
Andridge, RR1
Foster, JE1
McClure, KE1
Coury, DL1
Paslakis, G1
Schredl, M1
Alm, B3
Sobanski, E3
Dalsgaard, S1
Nielsen, HS1
Simonsen, M1
Philipsen, A1
Graf, E1
Jans, T1
Matthies, S1
Borel, P1
Colla, M1
Gentschow, L1
Langner, D1
Jacob, C1
Groß-Lesch, S1
Schumacher-Stien, M1
Roesler, M1
Retz, W1
Retz-Junginger, P1
Kis, B1
Abdel-Hamid, M1
Heinrich, V1
Huss, M1
Kornmann, C1
Bürger, A1
van Elst, LT1
Berger, M1
Steinhausen, HC1
Bisgaard, C1
Piñeiro-Dieguez, B1
Balanzá-Martínez, V1
García-García, P1
Soler-López, B1
Victor, MM1
Rovaris, DL1
Salgado, CA1
Silva, KL1
Karam, RG1
Vitola, ES1
Picon, FA1
Contini, V1
Guimarães-da-Silva, PO1
Blaya-Rocha, P1
Belmonte-de-Abreu, PS1
Rohde, LA1
Grevet, EH1
Bau, CH1
Chiang, HL1
Gau, SS1
Durak, S1
Ercan, ES1
Ardic, UA1
Yuce, D1
Ercan, E1
Ipci, M1
Fredriksen, M1
Dahl, AA1
Martinsen, EW1
Klungsøyr, O1
Haavik, J1
Peleikis, DE1
Peles, E1
Schreiber, S1
Linzy, S1
Domani, Y1
Adelson, M1
Ji, NY1
Findling, RL2
Dymowski, AR1
Ponsford, JL1
Owens, JA1
Olver, JH1
Ponsford, M1
Willmott, C1
Purper-Ouakil, D1
Vitiello, B2
Deutsch, CK1
Dube, WV1
McIlvane, WJ1
Surman, CB1
Adamson, JJ1
Petty, C1
Biederman, J6
Kenealy, DC1
Levine, M1
Mick, E2
Spencer, T4
Surman, C1
Schelleman, H1
Bilker, WB1
Kimmel, SE1
Daniel, GW1
Newcomb, C1
Guevara, JP1
Cziraky, MJ1
Strom, BL1
Hennessy, S1
Al Owesie, RM1
Morton, CS1
Huang, FL1
Huang, KP1
Herdener, M1
Oppliger, R1
Stohler, R1
Caflisch, C1
Kraut, AA1
Langner, I1
Lindemann, C1
Petermann, U1
Petermann, F1
Mikolajczyk, RT1
Garbe, E1
Safer, DJ1
Zito, JM1
DosReis, S1
Richard, I1
Perrouin-Verbe, B1
Rome, J1
Bernat, C1
Mathé, JF1
FERGUSON, JT5
FUNDERBURK, WH1
ALEMA, G2
SERGIO, C2
DUBE, AH1
OSGOOD, CK1
NOTKIN, H1
TYBRING, GB1
PENNINGTON, VM3
SOMMERNESS, MD1
LUCERO, RJ1
SHEA, JG1
SCHULTZ, JD1
LEWIS, E1
FAZEKAS, JF1
FREED, H1
WODRASKA, TW1
SAUNDERS, JC1
KLINE, NS1
BARUCCI, M1
MORI, F1
ZIMMERMAN, FT1
BURGEMEISTER, BB1
NISWANDER, GD1
HOLT, EK1
DARVILL, FT1
WOOLLEY, S1
KERENYI, AB1
KORANYI, EK1
SARWERFONER, GJ1
KOZLOWSKI, VL1
ZYCHIEWICZ-KRANKOWSKA, D1
SIVADON, P1
SALINGER, R1
GUILE, LA1
GUYOTAT, J1
HOCHMANN, J1
FAZIO, C1
GIBERTI, F1
ROSSI, R1
DECAROLIS, V1
JOHNSEN, G1
LEHMANN, HE2
BAN, TA3
JORGENSEN, F1
KODAHL, T1
Bryois, C1
Nanzer, N1
Eliez, S1
Etter, M1
Aubry, JM1
Bertschy, G1
Hugtenburg, JG1
Griekspoor, JE1
De Boer, I1
Heerdink, ER1
Tso, YH1
Egberts, AC1
Laqueille, X1
Dervaux, A1
El Omari, F1
Kanit, M1
Baylé, FJ1
van der Meulen, EM1
Bakker, SC1
Pauls, DL1
Oteman, N1
Kruitwagen, CL1
Pearson, PL1
Sinke, RJ1
Krumm, B1
Sussman, S1
Pentz, MA1
Spruijt-Metz, D1
Miller, T1
van der Oord, S1
Prins, PJ1
Oosterlaan, J1
Emmelkamp, PM1
Padala, PR1
Burke, WJ1
Bhatia, SC1
Petty, F1
Kösters, M1
Weinmann, S1
Becker, T1
Bolaños, CA1
Willey, MD1
Maffeo, ML1
Powers, KD1
Kinka, DW1
Grausam, KB1
Henderson, RP1
Goodman, DW1
Weih, M1
Thürauf, N1
Bleich, S1
Kornhuber, J1
Gleason, MM1
Egger, HL1
Emslie, GJ1
Greenhill, LL2
Kowatch, RA1
Lieberman, AF1
Luby, JL1
Owens, J1
Scahill, LD1
Scheeringa, MS1
Stafford, B1
Wise, B1
Zeanah, CH1
Barton, R1
Vaughan, BS1
Wetzel, MW1
Kratochvil, CJ1
Eggers, C1
Heimann, G1
Mattes, JA1
Boswell, L1
Oliver, H1
Huey, LY2
Janowsky, DS3
Judd, L1
Whitehall, W1
Zetin, M1
Risch, SC1
Loevinger, B1
Judd, LL1
Roitman, NA1
Clopton, PL1
Segal, D1
Hall, L1
Parker, D1
Salzinger, K1
Kwentus, JA1
Weitzner, MA2
Meyers, CA2
Valentine, AD2
Simeon, JG1
Wiggins, DM1
Williams, E1
Holmes, VF2
Aman, MG1
Wolford, PL1
Klein, RG1
Wilens, T1
Ablon, JS1
Lapey, K1
Kaelin, DL1
Cifu, DX1
Matthies, B1
Levin, VA1
Wilens, TE1
Byrne, JM1
Bawden, HN1
DeWolfe, NA1
Beattie, TL1
Markowitz, JS1
Morrison, SD1
DeVane, CL1
Kittur, S1
Hauser, P1
Paternite, CE1
Loney, J1
Salisbury, H1
Whaley, MA1
Homsi, J1
Walsh, D1
Nelson, KA1
Bridgeford, D1
Arciniegas, DB1
Batkis, M1
Sandberg, E1
Beresford, TP1
Kafka, MP1
Hennen, J1
Kooij, JJ1
Aeckerlin, LP1
Kolata, G1
Mills, C1
O'Leary, JC1
Short, EJ1
Manos, MJ1
Fernandez, F2
Solow, RA1
Billiard, M1
Guilleminault, C1
Dement, WC1
Chiles, JA1
Wilkus, RJ1
Corbett, JA1
Yassa, R1
Nair, NP1
Satterfield, JH1
Cantwell, DP1
Satterfield, BT1
Crook, T1
Clark, AN1
Leichner, PP1
Reid, AE1
Angrist, B1
d'Hollosy, M1
Sanfilipo, M1
Satriano, J1
Diamond, G1
Simberkoff, M1
Weinreb, H1
Blake, LM1
Warneke, L1
McDaniel, KD1
Levy, JK1
Chiarello, RJ1
Cole, JO1
Bruera, E1
Brenneis, C1
Paterson, AH1
MacDonald, RN1
Scarnati, R1
Goldmeier, D1
Fann, WE3
Livingstone, D1
St Jean, A1
Sterlin, C1
Noe, W1
Glassman, AH1
Perel, JM1
Davis, JM1
Wilson, IC1
Unwin, JR1
Schulze, HA1
Saavedra, V1

Clinical Trials (6)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Adjuvant Effects of Vitamin A and Vitamin D Supplementation on Treatment of Children With ADHD:A Randomized, Double Blind, Placebo-controlled, Multicentric Trial.[NCT04284059]Phase 4504 participants (Anticipated)Interventional2021-02-25Recruiting
Effects of Structured Skills Training Group in Treatment of ADHD in Adults: a Controlled Multicentre Study[NCT02685254]120 participants (Anticipated)Interventional2016-02-01Completed
A Follow-up, Family Study on Attention-deficit Hyperactivity Disorder[NCT00417781]1,800 participants (Actual)Observational2005-01-31Completed
Endophenotype, Molecular Genetic Study on Attention-deficit/ Hyperactivity Disorder[NCT00529906]200 participants (Actual)Observational2007-08-31Completed
Efficacy of Cognitive Behavioral Therapy in Treatment of Adults With Attention Deficit Hyperactivity Disorder[NCT02210728]200 participants (Anticipated)Interventional2006-04-30Active, not recruiting
Conscious Dying/Conscious Living: Ketamine-Assisted Psychotherapy (KAP) for Patients at End of Life-A Pilot Study for Palliative and Hospice Care[NCT05214417]Phase 2120 participants (Anticipated)Interventional2022-05-01Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

34 reviews available for methylphenidate and Behavior Disorders

ArticleYear
Neurological and psychiatric adverse effects of long-term methylphenidate treatment in ADHD: A map of the current evidence.
    Neuroscience and biobehavioral reviews, 2019, Volume: 107

    Topics: Attention Deficit Disorder with Hyperactivity; Brain Diseases; Central Nervous System Stimulants; Hu

2019
The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities.
    Neuroscience and biobehavioral reviews, 2018, Volume: 87

    Topics: Adrenergic Uptake Inhibitors; Amphetamine; Animals; Attention Deficit Disorder with Hyperactivity; B

2018
[Side effects of methylphenidate in children and the young].
    Revista de neurologia, 2018, Mar-01, Volume: 66, Issue:5

    Topics: Adolescent; Anorexia; Attention Deficit Disorder with Hyperactivity; Bone Diseases, Developmental; C

2018
[Adult attention deficit/hyperactivity disorder, associated symptoms and comorbid psychiatric disorders: diagnosis and pharmacological treatment].
    Fortschritte der Neurologie-Psychiatrie, 2013, Volume: 81, Issue:8

    Topics: Adult; Anxiety; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Co

2013
Pharmacotherapy for mental health problems in people with intellectual disability.
    Current opinion in psychiatry, 2016, Volume: 29, Issue:2

    Topics: Aggression; Anticonvulsants; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Ce

2016
[Use of psychotropic drugs in children].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2008, Volume: 15, Issue:12

    Topics: Adolescent; Age Factors; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety Dis

2008
Attention deficits, Attention-Deficit Hyperactivity Disorder, and intellectual disabilities.
    Developmental disabilities research reviews, 2008, Volume: 14, Issue:4

    Topics: Attention Deficit Disorder with Hyperactivity; Brain; Central Nervous System Stimulants; Child; Chro

2008
[Treating cocaine addiction].
    Praxis, 2012, Aug-08, Volume: 101, Issue:16

    Topics: Acetylcysteine; Alcohol Deterrents; Baclofen; Benzhydryl Compounds; Central Nervous System Stimulant

2012
Concomitant psychotropic medication for youths.
    The American journal of psychiatry, 2003, Volume: 160, Issue:3

    Topics: Adolescent; Age Factors; Child; Community Mental Health Centers; Drug Therapy, Combination; Drug Uti

2003
[Pharmacological treatment of post-traumatic behavioural disorders].
    Annales de readaptation et de medecine physique : revue scientifique de la Societe francaise de reeducation fonctionnelle de readaptation et de medecine physique, 2003, Volume: 46, Issue:1

    Topics: Adrenergic beta-Antagonists; Aggression; Anti-Anxiety Agents; Antidepressive Agents; Antimanic Agent

2003
PHARMACODYNAMIC REACTIVITY IN MENTAL PATIENTS MEASURED BY FRACTIONED "WECKANALYSE".
    Comprehensive psychiatry, 1963, Volume: 4

    Topics: Amobarbital; Amphetamine; Amphetamines; Blood Pressure; Drug Tolerance; Electroconvulsive Therapy; H

1963
[Psychiatry].
    Revue medicale suisse, 2005, Jan-12, Volume: 1, Issue:2

    Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperacti

2005
Misuse of "study drugs:" prevalence, consequences, and implications for policy.
    Substance abuse treatment, prevention, and policy, 2006, Jun-09, Volume: 1

    Topics: Adolescent; Adult; Amphetamines; Cardiovascular Diseases; Central Nervous System Stimulants; Emotion

2006
The consequences of attention-deficit/hyperactivity disorder in adults.
    Journal of psychiatric practice, 2007, Volume: 13, Issue:5

    Topics: Achievement; Adult; Age Factors; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder

2007
[Off-label use in psychiatry].
    Fortschritte der Neurologie-Psychiatrie, 2008, Volume: 76, Issue:1

    Topics: Attention Deficit Disorder with Hyperactivity; Drug Approval; Drug Prescriptions; Drug Utilization;

2008
Psychopharmacological treatment for very young children: contexts and guidelines.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2007, Volume: 46, Issue:12

    Topics: Algorithms; Amphetamines; Antidepressive Agents; Antipsychotic Agents; Atomoxetine Hydrochloride; At

2007
Use of medication in children with psychiatric disorders.
    Community practitioner : the journal of the Community Practitioners' & Health Visitors' Association, 2007, Volume: 80, Issue:11

    Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Child Psychiatry; D

2007
Beyond the 'typical' patient: treating attention-deficit/hyperactivity disorder in preschoolers and adults.
    International review of psychiatry (Abingdon, England), 2008, Volume: 20, Issue:2

    Topics: Adult; Age Factors; Age of Onset; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperac

2008
Interviewing with intravenous drugs.
    The Journal of clinical psychiatry, 1981, Volume: 42, Issue:11

    Topics: Amobarbital; Double-Blind Method; Humans; Injections, Intravenous; Interview, Psychological; Memory;

1981
Medical use of psychostimulants: an overview.
    International journal of psychiatry in medicine, 1995, Volume: 25, Issue:1

    Topics: Central Nervous System Stimulants; Depressive Disorder; Dextroamphetamine; Drug Interactions; Humans

1995
The role of methylphenidate in psychiatry.
    Archives of general psychiatry, 1995, Volume: 52, Issue:6

    Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Child; Cost-Benefit Analysis; Fema

1995
Attention-deficit/hyperactivity disorder: a life-span perspective.
    The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 7

    Topics: Adolescent; Adult; Age Factors; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hy

1998
Diagnosing attention-deficit/hyperactivity disorder in children.
    The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 7

    Topics: Adolescent; Adult; Age Factors; Attention Deficit Disorder with Hyperactivity; Child; Child, Prescho

1998
Adults with attention-deficit/hyperactivity disorder: a controversial diagnosis.
    The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 7

    Topics: Adolescent; Adult; Age Factors; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit

1998
Psychostimulants in supportive care.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2000, Volume: 8, Issue:5

    Topics: Adult; Caffeine; Central Nervous System Stimulants; Child; Dextroamphetamine; Ephedrine; Humans; Men

2000
Psychopharmacology for young children: clinical needs and research opportunities.
    Pediatrics, 2001, Volume: 108, Issue:4

    Topics: Age Factors; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Humans; Mental

2001
Neuropsychiatric aspects of human immunodeficiency virus (HIV) infection.
    Current psychiatry reports, 2002, Volume: 4, Issue:3

    Topics: AIDS Dementia Complex; Central Nervous System Stimulants; Cognition Disorders; HIV Seropositivity; H

2002
Behavioural and drug treatment of children with severe mental handicap.
    The British journal of psychiatry : the journal of mental science, 1975, Volume: Spec No 9

    Topics: Amphetamines; Anti-Anxiety Agents; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Bar

1975
Somatic therapies in geriatric psychiatry.
    Psychiatric medicine, 1991, Volume: 9, Issue:2

    Topics: Aged; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Central Nervous System Stimu

1991
Psychostimulants in psychiatry.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1990, Volume: 35, Issue:1

    Topics: Adult; Depressive Disorder; Dextroamphetamine; Female; Humans; Male; Mental Disorders; Methylphenida

1990
Pharmacologic treatment of psychiatric and neurodevelopmental disorders in children and adolescents (Part 1).
    Clinical pediatrics, 1986, Volume: 25, Issue:2

    Topics: Adolescent; Aggression; Antidepressive Agents; Antipsychotic Agents; Anxiety, Separation; Attention

1986
The use of psychostimulants in general psychiatry. A reconsideration.
    Archives of general psychiatry, 1987, Volume: 44, Issue:3

    Topics: Adult; Amphetamine; Central Nervous System Stimulants; Clinical Trials as Topic; Depressive Disorder

1987
Some clinically important interactions of psychotropic drugs.
    Southern medical journal, 1973, Volume: 66, Issue:6

    Topics: Antidepressive Agents; Biological Transport; Catecholamines; Central Nervous System; Central Nervous

1973
The clinical pharmacology of imipramine. Implications for therapeutics.
    Archives of general psychiatry, 1973, Volume: 28, Issue:5

    Topics: Administration, Oral; Barbiturates; Cell Membrane Permeability; Depression; Desipramine; Drug Intera

1973

Trials

19 trials available for methylphenidate and Behavior Disorders

ArticleYear
A randomized controlled multicenter trial on the multimodal treatment of adult attention-deficit hyperactivity disorder: enrollment and characteristics of the study sample.
    Attention deficit and hyperactivity disorders, 2014, Volume: 6, Issue:1

    Topics: Adult; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Clinical Protocols; Combined

2014
The efficacy and safety of extended-release methylphenidate following traumatic brain injury: a randomised controlled pilot study.
    Clinical rehabilitation, 2017, Volume: 31, Issue:6

    Topics: Adult; Brain Injuries, Traumatic; Central Nervous System Stimulants; Cross-Over Studies; Double-Blin

2017
Is response to OROS-methylphenidate treatment moderated by treatment with antidepressants or psychiatric comorbidity? A secondary analysis from a large randomized double blind study of adults with ADHD.
    CNS neuroscience & therapeutics, 2012, Volume: 18, Issue:2

    Topics: Administration, Oral; Adult; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; C

2012
Does brief, clinically based, intensive multimodal behavior therapy enhance the effects of methylphenidate in children with ADHD?
    European child & adolescent psychiatry, 2007, Volume: 16, Issue:1

    Topics: Adrenergic Uptake Inhibitors; Adult; Attention Deficit Disorder with Hyperactivity; Behavior Therapy

2007
Methylphenidate effects on symptoms of attention deficit disorder in adults.
    Archives of general psychiatry, 1984, Volume: 41, Issue:11

    Topics: Adolescent; Adult; Age Factors; Attention Deficit Disorder with Hyperactivity; Child; Clinical Trial

1984
Effects of methylphenidate in adult psychiatric inpatients: a preliminary report.
    Psychopharmacology bulletin, 1984,Winter, Volume: 20, Issue:1

    Topics: Adult; Female; Humans; Male; Mental Disorders; Methylphenidate; Middle Aged

1984
The effects of naloxone on methylphenidate-induced mood and behavioral changes: a negative study.
    Psychopharmacology, 1980, Volume: 67, Issue:2

    Topics: Behavior; Drug Interactions; Emotions; Growth Hormone; Humans; Mental Disorders; Methylphenidate; Na

1980
Consumer satisfaction with involvement in drug research: a social validity study.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1995, Volume: 34, Issue:7

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Clinical Trials

1995
A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder.
    Archives of general psychiatry, 1995, Volume: 52, Issue:6

    Topics: Adolescent; Adult; Age Factors; Ambulatory Care; Anxiety Disorders; Attention Deficit Disorder with

1995
Methylphenidate effect on attention deficit in the acutely brain-injured adult.
    Archives of physical medicine and rehabilitation, 1996, Volume: 77, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Attention; Brain Injuries; Central Nervous Sys

1996
Methylphenidate therapy improves cognition, mood, and function of brain tumor patients.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:7

    Topics: Adolescent; Adult; Affect; Aged; Brain; Brain Neoplasms; Central Nervous System Stimulants; Cognitio

1998
Clinical assessment of psychopharmacological treatment of preschoolers with ADHD.
    Journal of clinical and experimental neuropsychology, 1998, Volume: 20, Issue:5

    Topics: Attention; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child,

1998
Psychostimulant augmentation during treatment with selective serotonin reuptake inhibitors in men with paraphilias and paraphilia-related disorders: a case series.
    The Journal of clinical psychiatry, 2000, Volume: 61, Issue:9

    Topics: Adult; Ambulatory Care; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimul

2000
Developmental aspects of psychostimulant treatment in children and adolescents with attention-deficit/hyperactivity disorder.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2001, Volume: 40, Issue:12

    Topics: Adolescent; Amphetamines; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stim

2001
Central nervous system stimulants as symptomatic treatments for AIDS-related neuropsychiatric impairment.
    Journal of clinical psychopharmacology, 1992, Volume: 12, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Adult; Dextroamphetamine; Humans; Male; Mental Disorders; Methyl

1992
Psychostimulant response in AIDS-related complex patients.
    The Journal of clinical psychiatry, 1989, Volume: 50, Issue:1

    Topics: AIDS-Related Complex; Clinical Trials as Topic; Depressive Disorder; Dextroamphetamine; Humans; Male

1989
The use of psychostimulants in general psychiatry. A reconsideration.
    Archives of general psychiatry, 1987, Volume: 44, Issue:3

    Topics: Adult; Amphetamine; Central Nervous System Stimulants; Clinical Trials as Topic; Depressive Disorder

1987
Clinical studies with propericiazine (R.P. 8909).
    Diseases of the nervous system, 1967, Volume: 28, Issue:8

    Topics: Acute Disease; Adolescent; Adult; Aged; Association; Behavior; Chlorpromazine; Chronic Disease; Clin

1967
Methylphenidate in tardive dyskinesia.
    The American journal of psychiatry, 1973, Volume: 130, Issue:8

    Topics: Administration, Oral; Basal Ganglia Diseases; Clinical Trials as Topic; Evaluation Studies as Topic;

1973

Other Studies

81 other studies available for methylphenidate and Behavior Disorders

ArticleYear
Caregiver survey of pharmacotherapy to treat attention deficit/hyperactivity disorder in individuals with Williams syndrome.
    Research in developmental disabilities, 2013, Volume: 34, Issue:5

    Topics: Adolescent; Amphetamines; Aortic Stenosis, Subvalvular; Attention Deficit Disorder with Hyperactivit

2013
Five-fold increase in national prevalence rates of attention-deficit/hyperactivity disorder medications for children and adolescents with autism spectrum disorder, attention-deficit/hyperactivity disorder, and other psychiatric disorders: a Danish registe
    Journal of child and adolescent psychopharmacology, 2013, Volume: 23, Issue:7

    Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervou

2013
Substance use disorders in association with attention-deficit/hyperactivity disorder, co-morbid mental disorders, and medication in a nationwide sample.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2014, Volume: 24, Issue:2

    Topics: Adolescent; Adult; Antidepressive Agents; Antipsychotic Agents; Attention Deficit Disorder with Hype

2014
Psychiatric Comorbidity at the Time of Diagnosis in Adults With ADHD: The CAT Study.
    Journal of attention disorders, 2016, Volume: 20, Issue:12

    Topics: Adult; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Comorbidity; Cross-Sectiona

2016
Severity but not comorbidities predicts response to methylphenidate in adults with attention-deficit/hyperactivity disorder: results from a naturalistic study.
    Journal of clinical psychopharmacology, 2014, Volume: 34, Issue:2

    Topics: Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Comorbidity

2014
Impact of executive functions on school and peer functions in youths with ADHD.
    Research in developmental disabilities, 2014, Volume: 35, Issue:5

    Topics: Adolescent; Age Factors; Attention Deficit Disorder with Hyperactivity; Case-Control Studies; Centra

2014
Impact of executive functions on school and peer functions in youths with ADHD.
    Research in developmental disabilities, 2014, Volume: 35, Issue:5

    Topics: Adolescent; Age Factors; Attention Deficit Disorder with Hyperactivity; Case-Control Studies; Centra

2014
Impact of executive functions on school and peer functions in youths with ADHD.
    Research in developmental disabilities, 2014, Volume: 35, Issue:5

    Topics: Adolescent; Age Factors; Attention Deficit Disorder with Hyperactivity; Case-Control Studies; Centra

2014
Impact of executive functions on school and peer functions in youths with ADHD.
    Research in developmental disabilities, 2014, Volume: 35, Issue:5

    Topics: Adolescent; Age Factors; Attention Deficit Disorder with Hyperactivity; Case-Control Studies; Centra

2014
Effect of methylphenidate on neurocognitive test battery: an evaluation according to the diagnostic and statistical manual of mental disorders, fourth edition, subtypes.
    Journal of clinical psychopharmacology, 2014, Volume: 34, Issue:4

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child;

2014
Effectiveness of one-year pharmacological treatment of adult attention-deficit/hyperactivity disorder (ADHD): an open-label prospective study of time in treatment, dose, side-effects and comorbidity.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2014, Volume: 24, Issue:12

    Topics: Adrenergic Uptake Inhibitors; Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disor

2014
Differences in methylphenidate abuse rates among methadone maintenance treatment patients in two clinics.
    Journal of substance abuse treatment, 2015, Volume: 54

    Topics: Adult; Attention Deficit Disorder with Hyperactivity; Benzodiazepines; Central Nervous System Stimul

2015
Recent NIMH clinical trials and implications for practice.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2008, Volume: 47, Issue:12

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System

2008
Association between attention-deficit/hyperactivity disorder and sleep impairment in adulthood: evidence from a large controlled study.
    The Journal of clinical psychiatry, 2009, Volume: 70, Issue:11

    Topics: Adolescent; Adult; Age of Onset; Attention Deficit Disorder with Hyperactivity; Comorbidity; Diagnos

2009
Methylphenidate and risk of serious cardiovascular events in adults.
    The American journal of psychiatry, 2012, Volume: 169, Issue:2

    Topics: Adult; Aged; Central Nervous System Stimulants; Cohort Studies; Databases, Factual; Death, Sudden, C

2012
Psychopharmacologic intervention after hemorrhagic basal ganglia damage.
    Journal of the neurological sciences, 2012, Nov-15, Volume: 322, Issue:1-2

    Topics: Adult; Basal Ganglia Hemorrhage; Cognition Disorders; Galantamine; Glasgow Coma Scale; Humans; Male;

2012
Methylphenidate improves the behavioral and cognitive deficits of neurogranin knockout mice.
    Genes, brain, and behavior, 2012, Volume: 11, Issue:7

    Topics: Animals; Cognition Disorders; Female; Gene Expression; Glial Fibrillary Acidic Protein; Hippocampus;

2012
Comorbidities in ADHD children treated with methylphenidate: a database study.
    BMC psychiatry, 2013, Jan-07, Volume: 13

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Cardiovascular Diseases; Case-Control Stu

2013
Methylphenidate in treatment of adults with Attention-Deficit/Hyperactivity Disorder.
    Journal of attention disorders, 2002, Volume: 6 Suppl 1

    Topics: Adolescent; Adult; Age Factors; Attention Deficit Disorder with Hyperactivity; Central Nervous Syste

2002
Improving senile behavior with reserpine and ritalin; new approach with use of methyl phenylpiperidylacetate.
    Journal of the American Medical Association, 1956, Jan-28, Volume: 160, Issue:4

    Topics: Aged; Antihypertensive Agents; Central Nervous System Stimulants; Disease; Mental Disorders; Methylp

1956
Successful therapeutic regimen for the management of behavior problems in the elderly.
    Journal of the American Geriatrics Society, 1956, Volume: 4, Issue:11

    Topics: Aged; Behavior; Disease Management; Humans; Mental Disorders; Methylphenidate; Reserpine; Tranquiliz

1956
Successful therapeutic regimen for the management of behavior problems in the elderly.
    Journal of the American Geriatrics Society, 1956, Volume: 4, Issue:11

    Topics: Aged; Behavior; Disease Management; Humans; Mental Disorders; Methylphenidate; Reserpine; Tranquiliz

1956
Successful therapeutic regimen for the management of behavior problems in the elderly.
    Journal of the American Geriatrics Society, 1956, Volume: 4, Issue:11

    Topics: Aged; Behavior; Disease Management; Humans; Mental Disorders; Methylphenidate; Reserpine; Tranquiliz

1956
Successful therapeutic regimen for the management of behavior problems in the elderly.
    Journal of the American Geriatrics Society, 1956, Volume: 4, Issue:11

    Topics: Aged; Behavior; Disease Management; Humans; Mental Disorders; Methylphenidate; Reserpine; Tranquiliz

1956
[Initial clinical experiences with a new psychomimetic substance].
    Rivista sperimentale di freniatria e medicina legale delle alienazioni mentali, 1956, Oct-01, Volume: 80, Issue:4

    Topics: Electroconvulsive Therapy; Mental Disorders; Methylphenidate; Psychosurgery; Psychotherapy

1956
[Initial clinical experiences with a new psychomimetic substance].
    Rivista sperimentale di freniatria e medicina legale delle alienazioni mentali, 1956, Oct-01, Volume: 80, Issue:4

    Topics: Electroconvulsive Therapy; Mental Disorders; Methylphenidate; Psychosurgery; Psychotherapy

1956
[Initial clinical experiences with a new psychomimetic substance].
    Rivista sperimentale di freniatria e medicina legale delle alienazioni mentali, 1956, Oct-01, Volume: 80, Issue:4

    Topics: Electroconvulsive Therapy; Mental Disorders; Methylphenidate; Psychosurgery; Psychotherapy

1956
[Initial clinical experiences with a new psychomimetic substance].
    Rivista sperimentale di freniatria e medicina legale delle alienazioni mentali, 1956, Oct-01, Volume: 80, Issue:4

    Topics: Electroconvulsive Therapy; Mental Disorders; Methylphenidate; Psychosurgery; Psychotherapy

1956
The effects of an analeptic (ritalin), an ataraxic (reserpine), and a placebo in senile states.
    Journal of chronic diseases, 1957, Volume: 5, Issue:2

    Topics: Aged; Aging; Central Nervous System Stimulants; Disease; Mental Disorders; Methylphenidate; Reserpin

1957
A new approach to the clinical management of treatment of behavior problems; progress report.
    Journal - Michigan State Medical Society, 1957, Volume: 56, Issue:10

    Topics: Behavior; Mental Disorders; Methylphenidate; Research Report; Reserpine

1957
Experience with the ataractic and alerting drugs at Mendota State Hospital.
    Wisconsin medical journal, 1957, Volume: 56, Issue:10

    Topics: Hospitals, State; Humans; Mental Disorders; Methylphenidate; Piperidines; Psychosurgery; Psychothera

1957
The phrenotropic action of ritalin as evaluated by an IBM rating scale.
    The American journal of psychiatry, 1958, Volume: 114, Issue:7

    Topics: Counseling; Electroconvulsive Therapy; Humans; Mental Disorders; Methylphenidate; Psychotherapy

1958
Phrenotropic action of methylphenidylacetate (ritalin).
    Diseases of the nervous system, 1957, Volume: 18, Issue:12

    Topics: Electroconvulsive Therapy; Mental Disorders; Methylphenidate; Psychosurgery; Psychotherapy

1957
The phrenotropic action of methyl-phenidylacetate hydrochloride.
    International record of medicine and general practice clinics, 1958, Volume: 171, Issue:1

    Topics: Electroconvulsive Therapy; Mental Disorders; Methylphenidate; Psychosurgery; Psychotherapy

1958
Pilot study of effects of stimulant drugs on regressed patients.
    Minnesota medicine, 1957, Volume: 40, Issue:12

    Topics: Central Nervous System Stimulants; Electroconvulsive Therapy; Humans; Mental Disorders; Mephentermin

1957
The clinical and cerebral action of promethazine and methylphenidate hydrochloride.
    The American journal of the medical sciences, 1958, Volume: 235, Issue:2

    Topics: Counseling; Humans; Medical Records; Mental Disorders; Methylphenidate; Promethazine; Psychoses, Alc

1958
The use of ritalin intravenously as a diagnostic adjuvant in psychiatry.
    The American journal of psychiatry, 1958, Volume: 114, Issue:10

    Topics: Humans; Mental Disorders; Methylphenidate; Psychiatry

1958
Combined ritalin and serpasil therapy in chronic psychoses.
    Diseases of the nervous system, 1958, Volume: 19, Issue:3

    Topics: Mental Disorders; Methylphenidate; Psychosurgery; Psychotherapy; Psychotic Disorders; Reserpine

1958
[Effects of reserpine combined with a psycho-analeptic drug on mental efficiency of the aged].
    Rivista di patologia nervosa e mentale, 1957, Volume: 78, Issue:3

    Topics: Aged; Arteriosclerosis; Central Nervous System Stimulants; Dementia; Mental Disorders; Methylphenida

1957
Action of methyl-phenidylacetate (ritalin) and reserpine in behavior disorders in children and adults.
    The American journal of psychiatry, 1958, Volume: 115, Issue:4

    Topics: Behavior; Conduct Disorder; Mental Disorders; Methylphenidate; Reserpine

1958
Combination reserpine-methylphenidate in epileptics with psychosis; final report.
    Diseases of the nervous system, 1958, Volume: 19, Issue:10

    Topics: Epilepsy; Mental Disorders; Methylphenidate; Psychotic Disorders; Reserpine

1958
Double blind evaluation of methylphenidate (ritalin) hydrochloride; its use in the management of institutionalized geriatric patients.
    Journal of the American Medical Association, 1959, Apr-11, Volume: 169, Issue:15

    Topics: Dementia; Disease Management; Double-Blind Method; Humans; Mental Disorders; Methylphenidate; Patien

1959
The use of intravenous methylphenidate (ritalin) in psychiatric interviewing.
    Canadian Medical Association journal, 1959, Jun-15, Volume: 80, Issue:12

    Topics: Mental Disorders; Methylphenidate; Neurologic Examination; Psychotherapy

1959
Depressive symptoms.
    Medical times, 1959, Volume: 87, Issue:7

    Topics: Depression; Depressive Disorder; Electroconvulsive Therapy; Mental Disorders; Methylphenidate; Psych

1959
[Effect of alpha-phenyl-2-piperidine methyl acetate (ritalin) on stupor].
    Polski tygodnik lekarski, 1959, Feb-09, Volume: 14, Issue:6

    Topics: Acetates; Electroconvulsive Therapy; Mental Disorders; Methylphenidate; Psychosurgery; Psychotherapy

1959
[Clinical study of a new psychoactive drug in psychiatry, RP-8228 or threo-levo-1-phenyl-1-(2-piperidyl)-1-acetoxymethane HCl].
    Annales medico-psychologiques, 1962, Volume: 120(1)

    Topics: Humans; Mental Disorders; Methylphenidate; Psychiatry; Psychosurgery; Psychotherapy; Psychotropic Dr

1962
Intravenous methylphenidate--a pilot study.
    The Medical journal of Australia, 1963, Jul-20, Volume: 50(2)

    Topics: Humans; Mental Disorders; Methylphenidate; Pilot Projects

1963
[The present status of RP-8228 in psychiatric therapeutics. Apropos of 32 recent cases].
    Lyon medical, 1962, Oct-28, Volume: 94

    Topics: Coal Tar; Humans; Mental Disorders; Methylphenidate

1962
[CLINICAL ASPECTS OF MODEL PSYCHOSES].
    Nordisk psykiatrisk tidsskrift. Nordic journal of psychiatry, 1964, Volume: 18

    Topics: Anorexia Nervosa; Convulsive Therapy; Hospitals, Psychiatric; Humans; Insulin; Lysergic Acid Diethyl

1964
NOTES FROM THE LOG-BOOK OF A PSYCHOPHARMACOLOGICAL RESEARCH UNIT. II.
    Canadian Psychiatric Association journal, 1964, Volume: 9

    Topics: Antidepressive Agents; Books; Dextroamphetamine; Diazepam; Geriatrics; Humans; Mental Disorders; Met

1964
Treatment of reserpine-induced depression with a new analeptic: phenidylate.
    Annals of the New York Academy of Sciences, 1955, Apr-15, Volume: 61, Issue:1

    Topics: Central Nervous System Stimulants; Depression; Depressive Disorder; Mental Disorders; Methylphenidat

1955
[On the abuse of Ritalin].
    Ugeskrift for laeger, 1961, Sep-15, Volume: 123

    Topics: Humans; Mental Disorders; Methylphenidate; Substance-Related Disorders

1961
Methylphenidate: use in daily practice.
    Pharmacy world & science : PWS, 2005, Volume: 27, Issue:3

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child;

2005
Methylphenidate effective in treating amphetamine abusers with no other psychiatric disorder.
    European psychiatry : the journal of the Association of European Psychiatrists, 2005, Volume: 20, Issue:5-6

    Topics: Adrenergic Agents; Amphetamine-Related Disorders; Amphetamines; Depressive Disorder; Female; Humans;

2005
High sibling correlation on methylphenidate response but no association with DAT1-10R homozygosity in Dutch sibpairs with ADHD.
    Journal of child psychology and psychiatry, and allied disciplines, 2005, Volume: 46, Issue:10

    Topics: Attention Deficit Disorder with Hyperactivity; Child; Comorbidity; Dopamine Agents; Dopamine Plasma

2005
[Effect of subtype and psychiatric comorbidities on methylphenidate treatment in adults with attention-deficit hyperactivity disorder].
    Der Nervenarzt, 2007, Volume: 78, Issue:3

    Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants;

2007
Treatment of apathy with methylphenidate.
    The Journal of neuropsychiatry and clinical neurosciences, 2007,Winter, Volume: 19, Issue:1

    Topics: Aged; Central Nervous System Stimulants; Dementia, Vascular; Depressive Disorder, Major; Drive; Fema

2007
[Methylphenidate in adults with attention-deficit/hyperactivity disorder].
    Der Nervenarzt, 2007, Volume: 78, Issue:9

    Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants;

2007
Antidepressant treatment can normalize adult behavioral deficits induced by early-life exposure to methylphenidate.
    Biological psychiatry, 2008, Feb-01, Volume: 63, Issue:3

    Topics: Analysis of Variance; Animals; Animals, Newborn; Antidepressive Agents; Behavior, Animal; Conditioni

2008
[Psychopharmacotherapy in child psychiatry (author's transl)].
    MMW, Munchener medizinische Wochenschrift, 1980, Dec-19, Volume: 122, Issue:51-52

    Topics: Adolescent; Amphetamines; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Brain; Child; Huma

1980
[Psychopharmaceuticals in pediatric practice].
    Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde, 1984, Volume: 132, Issue:6

    Topics: Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Child; Dose-Response Relationship,

1984
The behavioral mechanism to explain abnormal behavior.
    Annals of the New York Academy of Sciences, 1980, Volume: 340

    Topics: Behavior; Chlorpromazine; Conditioning, Operant; Dose-Response Relationship, Drug; Extinction, Psych

1980
Methylphenidate in the treatment of neurobehavioral slowing associated with cancer and cancer treatment.
    The Journal of neuropsychiatry and clinical neurosciences, 1995,Summer, Volume: 7, Issue:3

    Topics: Aged; Antineoplastic Agents; Arousal; Astrocytoma; Attention; Brain Neoplasms; Central Nervous Syste

1995
World wide use of psychotropic drugs in child and adolescent psychiatric disorders.
    Progress in neuro-psychopharmacology & biological psychiatry, 1995, Volume: 19, Issue:3

    Topics: Adolescent; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Canada; Child; Chi

1995
Drug interactions with psychostimulants.
    International clinical psychopharmacology, 1999, Volume: 14, Issue:1

    Topics: Anticonvulsants; Antidepressive Agents; Antihypertensive Agents; Antipsychotic Agents; Dextroampheta

1999
Improvement of sleep and behavior by methylphenidate in Alzheimer's disease.
    The American journal of psychiatry, 1999, Volume: 156, Issue:7

    Topics: Aged; Alzheimer Disease; Drug Administration Schedule; Hospitalization; Humans; Male; Mental Disorde

1999
Childhood inattention-overactivity, aggression, and stimulant medication history as predictors of young adult outcomes.
    Journal of child and adolescent psychopharmacology, 1999, Volume: 9, Issue:3

    Topics: Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Foll

1999
Methylphenidate treatment of neuropsychiatric symptoms of central and extrapontine myelinolysis.
    Journal of studies on alcohol, 2000, Volume: 61, Issue:5

    Topics: Alcoholism; Central Nervous System Stimulants; Chronic Disease; Corpus Striatum; Humans; Magnetic Re

2000
[Functioning, comorbidity and treatment of 141 adults with attention deficit hyperactivity disorder (ADHD) at a psychiatric outpatient department].
    Nederlands tijdschrift voor geneeskunde, 2001, Aug-04, Volume: 145, Issue:31

    Topics: Adrenergic alpha-Agonists; Adult; Age Factors; Attention Deficit Disorder with Hyperactivity; Centra

2001
Boom in Ritalin sales raises ethical issues.
    The New York times on the Web, 1996, May-15

    Topics: Adult; Attention Deficit Disorder with Hyperactivity; Behavior; Behavior Control; Child; Health; Hum

1996
One pill makes you smarter: an ethical appraisal of the rise of Ritalin.
    Report from the Institute for Philosophy & Public Policy, 1998,Fall, Volume: 18, Issue:4

    Topics: Behavior; Behavior Control; Biomedical Enhancement; Child; Ethics; Goals; Humans; Hyperkinesis; Ment

1998
An analysis of the legal issue surrounding the forced use of Ritalin: protecting a child's right to "just say no.
    New England law review, 1993,Summer, Volume: 27, Issue:4

    Topics: Administrative Personnel; Behavior; Behavior Control; Child; Civil Rights; Coercion; Decision Making

1993
Stimulants and other drugs for treatment of mental symptoms in the elderly.
    The Medical letter on drugs and therapeutics, 1978, Aug-25, Volume: 20, Issue:17

    Topics: Aged; Central Nervous System Stimulants; Cognition Disorders; Humans; Mental Disorders; Methylphenid

1978
Psychopharmacology with adolescents: a current review.
    Adolescent psychiatry, 1978, Volume: 6

    Topics: Adolescent; Amphetamines; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agent

1978
A menstruation-linked periodic hypersomnia. Kleine-Levin syndrome or new clinical entity?
    Neurology, 1975, Volume: 25, Issue:5

    Topics: Adolescent; Disorders of Excessive Somnolence; Electroencephalography; Estrogens, Conjugated (USP);

1975
Behavioral manifestations of the Kleine-Levin syndrome.
    Diseases of the nervous system, 1976, Volume: 37, Issue:11

    Topics: Adolescent; Behavior; Disorders of Excessive Somnolence; Electroencephalography; Humans; Male; Menta

1976
The Kleine-Levine syndrome--a variant?
    The Journal of clinical psychiatry, 1978, Volume: 39, Issue:3

    Topics: Adult; Disorders of Excessive Somnolence; Feeding and Eating Disorders; Humans; Hypothalamus; Male;

1978
Multimodality treatment. A one-year follow-up of 84 hyperactive boys.
    Archives of general psychiatry, 1979, Volume: 36, Issue:9

    Topics: Achievement; Antisocial Personality Disorder; Child; Follow-Up Studies; Humans; Hyperkinesis; Intell

1979
Central-nervous-system stimulants: appraisal of use in geropsychiatric patients.
    Journal of the American Geriatrics Society, 1979, Volume: 27, Issue:10

    Topics: Aged; Humans; Mental Disorders; Methylphenidate; Pentylenetetrazole

1979
Morale and motivation.
    The Practitioner, 1978, Volume: 220, Issue:1319

    Topics: Aged; Dextroamphetamine; Diagnosis, Differential; Female; Humans; Male; Mental Disorders; Methylphen

1978
Intravenous methylphenidate as a diagnostic and psychotherapeutic instrument in adult psychiatry.
    Canadian Psychiatric Association journal, 1976, Volume: 21, Issue:7

    Topics: Abreaction; Adult; Alcoholism; Antisocial Personality Disorder; Anxiety; Defense Mechanisms; Depress

1976
Narcotics plus methylphenidate (Ritalin) for advanced cancer pain.
    The American journal of nursing, 1988, Volume: 88, Issue:11

    Topics: Drug Therapy, Combination; Humans; Mental Disorders; Methylphenidate; Narcotics; Neoplasms; Pain

1988
An outline of hazardous side effects of Ritalin (methylphenidate).
    The International journal of the addictions, 1986, Volume: 21, Issue:7

    Topics: Bibliographies as Topic; Child; Humans; Mental Disorders; Methylphenidate

1986
Psychosocial aspects of AIDS.
    British journal of hospital medicine, 1987, Volume: 37, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Attitude to Health; Brain Diseases; Child; Dementia; Dextroamphe

1987
Interactions of psychotropic drugs in the elderly.
    Postgraduate medicine, 1973, Volume: 53, Issue:3

    Topics: Aged; Antacids; Anticonvulsants; Antipsychotic Agents; Biological Transport, Active; Chlorothiazide;

1973
Some general observations on the usefulness of lysergic acid in psychiatry.
    The New Zealand medical journal, 1966, Volume: 65, Issue:410

    Topics: Amobarbital; Amphetamine; Drug Synergism; Humans; Lysergic Acid Diethylamide; Mental Disorders; Meth

1966
Intravenous methylphenidate-facilitation of psychotherapy with recalcitrant yount.
    Acta paedopsychiatrica, 1968, Volume: 35, Issue:9

    Topics: Adolescent; Humans; Injections, Intravenous; Male; Mental Disorders; Methylphenidate; Physician-Pati

1968
[Trends and perspectives of psychopharmacology].
    Zeitschrift fur arztliche Fortbildung, 1970, Oct-15, Volume: 64, Issue:20

    Topics: Amphetamine; Antidepressive Agents; Caffeine; Hallucinogens; Humans; Hypnotics and Sedatives; Mental

1970
Comparative pharmacotherapy of the aging psychotic patient.
    Laval medical, 1967, Volume: 38, Issue:6

    Topics: Aged; Amitriptyline; Fluoxymesterone; Humans; Mental Disorders; Meprobamate; Methylphenidate; Nicoti

1967
[Euphoria-analysis as a technic of psychiatric exploration. The use of alpha-phenyl-2-piperidineacetic acid methyl ester hydrochloride].
    Revista de neuro-psiquiatria, 1966, Volume: 29, Issue:1

    Topics: Adolescent; Adult; Euphoria; Female; Humans; Mental Disorders; Methylphenidate; Middle Aged

1966